Published in Endoscopy on December 01, 2003
Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol (2007) 2.07
Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut (2005) 1.78
Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease. Int J Colorectal Dis (2005) 1.28
Percutaneous paraumbilical embolization as an unconventional and successful treatment for bleeding jejunal varices. World J Gastroenterol (2009) 1.26
A prospective study on evaluating the diagnostic yield of video capsule endoscopy followed by directed double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. Dig Dis Sci (2009) 1.12
Duodenal carcinoma at the ligament of Treitz. A molecular and clinical perspective. BMC Gastroenterol (2010) 1.09
Guideline for capsule endoscopy: obscure gastrointestinal bleeding. Clin Endosc (2013) 1.08
Wireless capsule endoscopy and Crohn's disease. Gut (2005) 1.06
Gastrointestinal capsule endoscopy: from tertiary centres to primary care. BMJ (2006) 1.04
CT enteroclysis: technique and clinical applications. Eur Radiol (2005) 1.02
New diagnostic imaging tools for inflammatory bowel disease. Gut (2006) 0.98
Factors associated with the clinical impact of capsule endoscopy in patients with overt obscure gastrointestinal bleeding. Dig Dis Sci (2009) 0.97
Obscure gastrointestinal bleeding: preliminary comparison of 64-section CT enteroclysis with video capsule endoscopy. Eur Radiol (2010) 0.96
Diagnostic yield, therapeutic impact, and complications of double-balloon enteroscopy in patients with small-bowel pathology. Surg Endosc (2007) 0.92
Role of video endoscopy in managing small bowel disease. Gut (2004) 0.92
Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature. World J Gastroenterol (2006) 0.90
Prevalence of mid-gastrointestinal bleeding in patients with acute overt gastrointestinal bleeding: multi-center experience with 1,044 consecutive patients. J Gastroenterol (2009) 0.90
Multidetector computed tomography enteroclysis (MDCT-E) with neutral enteral and IV contrast enhancement in tumor detection. Eur Radiol (2005) 0.90
Bleeding lesions within reach of conventional endoscopy in capsule endoscopy examinations for obscure gastrointestinal bleeding: is repeating endoscopy economically feasible? Dig Dis Sci (2011) 0.89
Clinical applications of small bowel capsule endoscopy. Clin Exp Gastroenterol (2013) 0.88
Five years' experience with capsule endoscopy in a single center. World J Gastroenterol (2009) 0.87
Efficacy of computed image modification of capsule endoscopy in patients with obscure gastrointestinal bleeding. World J Gastrointest Endosc (2012) 0.86
Comparison of MR enteroclysis with video capsule endoscopy in the investigation of small-intestinal disease. Abdom Imaging (2013) 0.85
Small bowel video capsule endoscopy in Crohn's disease: What have we learned in the last ten years? World J Gastrointest Endosc (2011) 0.83
Rebleeding rate after interventional therapy directed by capsule endoscopy in patients with obscure gastrointestinal bleeding. BMC Gastroenterol (2008) 0.82
Evaluation and outcomes of patients with obscure gastrointestinal bleeding. World J Gastrointest Pathophysiol (2014) 0.82
Is it possible to predict the presence of intestinal angioectasias? Diagn Ther Endosc (2014) 0.82
18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease. Dig Dis Sci (2012) 0.80
The Role of Capsule Endoscopy in Patients with Obscure Gastrointestinal Bleeding. Clin Endosc (2016) 0.79
Helical CT-enteroclysis in the detection of small-bowel tumours: a meta-analysis. Eur Radiol (2012) 0.79
Capsule endoscopy in the evaluation of obscure gastrointestinal bleeding: a comprehensive review. Gastroenterol Hepatol (N Y) (2007) 0.78
Obscure gastrointestinal bleeding: diagnostic performance of 64-section multiphase CT enterography and CT angiography compared with capsule endoscopy. Br J Radiol (2014) 0.78
Impact of capsule endoscopy findings on patient outcomes. Dig Dis Sci (2009) 0.77
Computed tomography enterography and magnetic resonance enterography: the future of small bowel imaging. Clin Colon Rectal Surg (2008) 0.77
Robotics in Colonoscopy. Am J Robot Surg (2014) 0.75
Analysis of Non-Small Bowel Lesions Detected by Capsule Endoscopy in Patients with Potential Small Bowel Bleeding. Diagn Ther Endosc (2016) 0.75
Asymptomatic ileal adenocarcinoma in the setting of undiagnosed Crohn's disease. World J Gastroenterol (2008) 0.75
Capsule endoscopy, technical impact, benefits and limitations. Langenbecks Arch Surg (2004) 0.75
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (1993) 3.42
Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death. Am J Transplant (2013) 2.88
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet (1999) 2.29
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut (2005) 2.17
Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med (1996) 2.16
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology (1998) 1.86
Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut (2005) 1.78
Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer (2000) 1.58
Successful living related kidney transplantation despite renal angiomyolipoma in situ. J Urol (1999) 1.57
Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Endoscopy (2006) 1.49
Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Dig Liver Dis (2004) 1.45
Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Gastroenterology (1997) 1.41
A method for adjusting a malpositioned bifurcated aortic endograft. J Endovasc Surg (1998) 1.39
[Food-dependent Cushing syndrome of long standing with mild clinical features]. Dtsch Med Wochenschr (2000) 1.38
ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr (2006) 1.37
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther (2006) 1.33
A respirometer for investigating oxidative cell metabolism: toward optimization of respiratory studies. Anal Biochem (1994) 1.32
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol (1989) 1.30
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol (2000) 1.26
Does passage of a patency capsule indicate small-bowel patency? A prospective clinical trial? Endoscopy (2005) 1.22
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease. Gut (2002) 1.17
Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med (1997) 1.12
Prevalence of malnutrition in 1760 patients at hospital admission: a controlled population study of body composition. Clin Nutr (2003) 1.10
Thalidomide for treatment of severe intestinal bleeding. Gut (2004) 1.09
Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther (2004) 1.09
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study. Ann Oncol (2002) 1.09
Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol (2006) 1.08
Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res (1996) 1.08
Nutrition in the elderly. Best Pract Res Clin Gastroenterol (2001) 1.07
HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma (1997) 1.06
Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci (1994) 1.06
Multislice CT coronary angiography: evaluation of an automatic vessel detection tool. Rofo (2004) 1.04
Is tube feeding with elemental diets a primary therapy of Crohn's disease? Klin Wochenschr (1984) 1.04
Variation of HMGB1 expression in breast cancer. Anticancer Res (2002) 1.04
Nutritional assessment and management in hospitalised patients: implication for DRG-based reimbursement and health care quality. Clin Nutr (2005) 1.03
Membrane proteins of chromaffin granules, dopamine -hydroxylase, a major constituent. Biochem J (1972) 1.02
Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand (2004) 1.02
Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology (2000) 1.02
Energy and substrate metabolism in patients with active Crohn's disease. J Nutr (1999) 1.01
Aspects of computer-aided detection (CAD) and volumetry of pulmonary nodules using multislice CT. Br J Radiol (2005) 1.01
Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol (1999) 1.01
Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease. Gastroenterology (2001) 1.01
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease. Gut (1997) 1.00
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther (2007) 1.00
Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease. Dig Dis Sci (1995) 1.00
Substance P is markedly increased in plasma of patients with hepatic coma. Lancet (1984) 1.00
The C/C(-13910) and G/G(-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease. Scand J Gastroenterol (2003) 0.98
Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol (1999) 0.98
Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol (1995) 0.97
High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol Histopathol (2003) 0.97
Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease. Endoscopy (1993) 0.97
Schwannoma with angiosarcoma. Report of a case and comparison with other types of nerve tumors with angiosarcoma. Cancer (2000) 0.96
Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res (1995) 0.96
Resection of ectopic mediastinal parathyroid glands with the da Vinci robotic system. Br J Surg (2010) 0.96
Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol (1997) 0.95
Helmholtz free energies of atom pair interactions in proteins. Fold Des (1996) 0.95
Bacterial biofilm within diseased pancreatic and biliary tracts. Gut (2005) 0.95
A new bronchoscopic method to measure airway size. Eur Respir J (1999) 0.94
[Gastric polyps in pernicious anemia: indications for polypectomy]. Dtsch Med Wochenschr (2000) 0.94
Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 0.94
Spatial organisation of microbiota in quiescent adenoiditis and tonsillitis. J Clin Pathol (2006) 0.93
Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study. Eur J Clin Nutr (2011) 0.92
Health-related quality of life in patients with Crohn's disease: influence of surgical operation--a prospective trial. Dig Dis Sci (1999) 0.92
Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease. Eur J Clin Pharmacol (2007) 0.92
Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions. Br J Cancer (2003) 0.91
Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man. Metabolism (1994) 0.91
[Prevalence of diabetes in acromegaly and Cushing syndrome]. Acta Med Austriaca (2000) 0.90
Mechanism of hepatic assimilation of dipeptides. Transport versus hydrolysis. J Biol Chem (1986) 0.90
Images in cardiology: Coronary artery stenosis caused by an aortic root abscess. Heart (2005) 0.89
Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab (2001) 0.89
Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis. Eur J Endocrinol (2006) 0.89
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. Eur J Gastroenterol Hepatol (1996) 0.88
[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]. Z Gastroenterol (2002) 0.88
Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem (2000) 0.88
Molecular and structural analysis of a continuous birch profilin epitope defined by a monoclonal antibody. J Biol Chem (1996) 0.88
Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology (Oxford) (2008) 0.87
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
Steroid dependency in Crohn's disease. Lancet (1995) 0.87
An extended nomenclature of the canine karyotype. Cytogenet Cell Genet (1996) 0.87
Algorithm for detection of small-bowel metastasis in malignant melanoma of the skin. Endoscopy (2011) 0.87
Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat. Oncogene (2003) 0.87
Non-invasive evaluation of activity in inflammatory bowel disease by power Doppler sonography. Z Gastroenterol (2002) 0.86
A R644C mutation within lamin A extends the mutations causing dilated cardiomyopathy. Hum Mutat (2001) 0.86
Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis. Rofo (2008) 0.86
Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr (2005) 0.86
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (2001) 0.85
Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Clin Exp Immunol (2008) 0.85
Evidence supports nutritional support. Clin Nutr (2006) 0.85
Cold atoms and molecules in self-assembled dipolar lattices. Phys Rev Lett (2008) 0.85
Diagnostic significance of endoscopic biopsy in Crohn's disease. Endoscopy (1989) 0.84